New research on amyotrophic lateral sclerosis (AML) has revealed that a protein called membralin plays a key role in the disease process. The study suggests that membralin-boosting gene therapy is a potential therapeutic direction to treat this often deadly disease.
from Healthy Aging News -- ScienceDaily http://bit.ly/2HBLtrw
No comments:
Post a Comment